Together or separately, these procedures can significantly improve the eye area's appearance, which often shows early signs of aging or volume changes after GLP-1 related weight loss
Tirzepatide, the active ingredient in Zepbound and Mounjaro, targets both GLP-1 and GIP receptors, two hormone pathways involved in appetite and metabolic regulation
GLP-1 medications are ideal for individuals with a body mass index (BMI) of 30 or higher, which is classified as obese, or a BMI of 27 or higher when accompanied by a weight-related medical condition
Higher doses don't always mean faster weight lossthey increase side effects and cost without proportional benefit
The team here are super professional and encouraging for my personal goals
FAQ How soon will I see results